CMPI - Checkmate Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Checkmate Pharmaceuticals's activity chart (see below) currently has 7 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 107.5 days.

Most recent stock forecast was given by from BTIG on 20-Apr-2022. First documented stock forecast 01-Sep-2020.

Best performing analysts who are covering CMPI - Checkmate Pharmaceuticals:

Geoff Meacham Kaveri Pohlman

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Sep-2020

$9

4 years 5 months ago
(20-Apr-2022)

1/2 (50%)

$5.78 (179.50%)

20

Hold Since 01-Sep-2020

$7

4 years 11 months 13 days ago
(07-Oct-2021)

1/2 (50%)

$2.71 (63.17%)

195

Show more analysts

Please expand the browser size to see the chart

What is CMPI (Checkmate Pharmaceuticals) average time for price targets to be met?

On average it took 108 days for the stock forecasts to be reached, with an average price target met ratio of 50%.

Which analyst most recently updated their price target on CMPI (Checkmate Pharmaceuticals)?

Which analyst has the most public recommendations on CMPI (Checkmate Pharmaceuticals)?

has 0 price targets and 0 ratings on CMPI

Which analyst is the currently most bullish on CMPI (Checkmate Pharmaceuticals)?

Geoff Meacham with the highest potential upside of $0

Which analyst is the currently most reserved on CMPI (Checkmate Pharmaceuticals)?

Geoff Meacham with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?